A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome
| Image |  |
|---|---|
| Description | scientific article published in March 2003 |
| Author/s |
author: Susan O'Brien Guillermo Garcia-Manero Michael Andreeff Jorge Eduardo Cortes Hagop Kantarjian Michael J. Keating Stefan Faderl Maher Albitar Elihu Estey Francis Giles |
| Publication date | March 1, 2003 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |